Peak Pharmaceuticals (PKPH) Short Interest Ratio & Short Volume → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free PKPH Stock Alerts $3.70 -0.10 (-2.63%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Peak Pharmaceuticals Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$400.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2023Outstanding Shares392,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume830 sharesAverage Trading Volume9,053 sharesToday's Volume Vs. Average9% Short Selling Peak Pharmaceuticals ? Sign up to receive the latest short interest report for Peak Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPKPH Short Interest Over TimePKPH Days to Cover Over TimePKPH Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Peak Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2023100 shares $400.00 No ChangeN/A0.1 $4.00 1/31/202324,200 shares $4,840.00 -30.9%N/A0 $0.20 1/15/202335,000 shares $4,896.50 +19.5%N/A0.1 $0.14 12/30/202229,300 shares $4,043.40 No ChangeN/A0 $0.14 11/30/202227,900 shares $1,757.70 +160.8%N/A0.9 $0.06 11/15/202210,700 shares $647.35 No ChangeN/A0.2 $0.06 Get the Latest News and Ratings for PKPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/30/2022100 shares $6.00 No ChangeN/A0 $0.06 9/15/2022100 shares $6.00 -66.7%N/A0 $0.06 8/31/2022300 shares $22.80 No ChangeN/A0 $0.08 7/31/20224,000 shares $264.00 No ChangeN/A0.1 $0.07 7/15/20224,000 shares $220.00 No ChangeN/A0.1 $0.06 6/15/2022400 shares $22.04 -96.1%N/A0 $0.06 5/31/202210,300 shares $719.97 +1,616.7%N/A0.5 $0.07 5/15/2022600 shares $33.00 No ChangeN/A0 $0.06 4/30/2022600 shares $34.38 No ChangeN/A0 $0.06 4/15/2022600 shares $51.00 -96.6%N/A0 $0.09 3/31/202217,800 shares $1,415.10 No ChangeN/A0.2 $0.08 11/30/20213,600 shares $262.80 No ChangeN/A0 $0.07 10/29/2021500 shares $60.25 -97.7%N/A0 $0.12 10/15/202121,300 shares $2,871.24 -24.7%N/A0.2 $0.13 9/30/202128,300 shares $3,679.00 +70.5%N/A0.1 $0.13 9/15/202116,600 shares $1,494.00 +348.7%N/A0.2 $0.09 8/31/20213,700 shares $343.36 No ChangeN/A0 $0.09 7/30/20214,600 shares $518.88 No ChangeN/A0 $0.11 6/15/20215,200 shares $634.40 -46.4%N/A0 $0.12 5/28/20219,700 shares $1,077.67 +546.7%N/A0.1 $0.11 5/14/20211,500 shares $165.00 -86.4%N/A0 $0.11 4/30/202111,000 shares $1,224.30 +103.7%N/A0 $0.11 4/15/20215,400 shares $783.00 No ChangeN/A0 $0.15 3/15/2021100 shares $14.00 -91.7%N/A0 $0.14 2/26/20211,200 shares $239.28 -73.9%N/A0 $0.20 2/12/20214,600 shares $755.55 -20.7%N/A0 $0.16 1/29/20215,800 shares $475.60 No ChangeN/A0 $0.08 1/15/202127,500 shares $2,117.50 No ChangeN/A0.1 $0.08 12/31/202027,500 shares $1,512.50 No ChangeN/A0.1 $0.06 12/15/202027,500 shares $830.50 No ChangeN/A0.1 $0.03 9/30/2020200 shares $2.40 No ChangeN/A0 $0.01 6/30/20201,000 shares $14.80 +100.0%N/A0 $0.01 6/15/2020500 shares $6.50 No ChangeN/A0 $0.01 5/29/2020500 shares $6.00 No ChangeN/A0 $0.01Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now PKPH Short Interest - Frequently Asked Questions What is Peak Pharmaceuticals' current short interest? Short interest is the volume of Peak Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 100 shares of PKPH short. Learn More on Peak Pharmaceuticals' current short interest. Is Peak Pharmaceuticals' short interest increasing or decreasing? Peak Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Peak Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Peak Pharmaceuticals: Baudax Bio, Inc. (1.11%), Tenax Therapeutics, Inc. (2.17%), Comera Life Sciences Holdings, Inc. (2.38%), Cingulate Inc. (0.29%), Biodexa Pharmaceuticals Plc (7.95%), SciSparc Ltd. (5.67%), Nexien BioPharma, Inc. (0.00%), Evelo Biosciences, Inc. (2.11%), Neptune Wellness Solutions Inc (0.54%), Dermata Therapeutics, Inc. (2.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.05 billion), Occidental Petroleum Co. ($3.06 billion), Moderna, Inc. ($2.37 billion), Paramount Global ($2.14 billion), T. Rowe Price Group, Inc. ($2.13 billion), Coinbase Global, Inc. ($2.00 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.77 billion), CarMax, Inc. ($1.59 billion), and Old Dominion Freight Line, Inc. ($1.56 billion). View all of the most shorted stocks. What does it mean to sell short Peak Pharmaceuticals stock? Short selling PKPH is an investing strategy that aims to generate trading profit from Peak Pharmaceuticals as its price is falling. PKPH shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Peak Pharmaceuticals? A short squeeze for Peak Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PKPH, which in turn drives the price of the stock up even further. How often is Peak Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PKPH, twice per month. The most recent reporting period available is April, 30 2023. More Short Interest Resources from MarketBeat Related Companies: Baudax Bio Short Interest Data Tenax Therapeutics Short Interest Data Comera Life Sciences Short Interest Data Cingulate Short Interest Data Biodexa Pharmaceuticals Short Interest Data SciSparc Short Interest Data Nexien BioPharma Short Interest Data Evelo Biosciences Short Interest Data Neptune Wellness Solutions Short Interest Data Dermata Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PKPH) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the MarketsMost important medical advance in 100 yearsThe Oxford Club